KR20210141271A - Composition for recylce a skin cell comprising of limonium tetragonum - Google Patents

Composition for recylce a skin cell comprising of limonium tetragonum Download PDF

Info

Publication number
KR20210141271A
KR20210141271A KR1020200058700A KR20200058700A KR20210141271A KR 20210141271 A KR20210141271 A KR 20210141271A KR 1020200058700 A KR1020200058700 A KR 1020200058700A KR 20200058700 A KR20200058700 A KR 20200058700A KR 20210141271 A KR20210141271 A KR 20210141271A
Authority
KR
South Korea
Prior art keywords
composition
collagen
skin cell
cell regeneration
active ingredient
Prior art date
Application number
KR1020200058700A
Other languages
Korean (ko)
Other versions
KR102545718B1 (en
Inventor
장선일
신재영
조병옥
박지현
임이택
Original Assignee
진안당 영농조합법인
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 진안당 영농조합법인 filed Critical 진안당 영농조합법인
Priority to KR1020200058700A priority Critical patent/KR102545718B1/en
Publication of KR20210141271A publication Critical patent/KR20210141271A/en
Application granted granted Critical
Publication of KR102545718B1 publication Critical patent/KR102545718B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Medical Informatics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a composition for regenerating skin cells, which includes Limonium tetragonum as an active ingredient.

Description

갯질경을 유효성분으로 포함하는 피부세포재생용 조성물{COMPOSITION FOR RECYLCE A SKIN CELL COMPRISING OF LIMONIUM TETRAGONUM}A composition for skin cell regeneration, comprising chives as an active ingredient {COMPOSITION FOR RECYLCE A SKIN CELL COMPRISING OF LIMONIUM TETRAGONUM}

본 발명은 갯질경을 유효성분으로 포함하는 피부세포재생용 조성물에 관한 것이다.The present invention relates to a composition for regenerating skin cells, which includes P.

갯질경은, 쌍떡잎식물 초롱꽃목 갯길경과의 두해살이풀로서, 바닷가에서 자라고, 뿌리가 굵고 곧게 자란다. 잎은 뿌리에서 뭉쳐나고 사방으로 퍼지며 긴 타원형 주걱 모양이고 털이 없으며 가장자리가 밋밋하다.The dicotyledonous plant is a biennial plant of the dicotyledonous plant Chrysanthemum, which grows on the seashore and has thick and straight roots. The leaves are clustered at the root, spread in all directions, have the shape of a long oval spatula, have no hairs, and have a flat edge.

꽃줄기는 30∼60cm로서 많은 가지가 갈라져 그 끝에 수상꽃차례의 꽃이삭이 달리는데 꽃이삭의 길이는 2∼4cm이다. 포는 녹색이고 타원형이며 몇 개의 꽃이 들어 있다. 꽃받침은 통 모양이고 끝이 5갈래로 갈라진다. 화관은 노란색이고 5갈래로 깊게 갈라지며 꽃받침보다 길다. 수술은 5개, 암술은 1개이며 5개의 암술대가 있다.The flower stalk is 30-60cm, and many branches are divided, and the spike of the stigma hangs at the end, and the length of the spike is 2-4cm. The bract is green, oval, and contains several flowers. The calyx is cylindrical and the tip is divided into 5 parts. The corolla is yellow, deeply divided into 5 parts and longer than the calyx. There are 5 stamens, 1 pistil, and 5 styles.

열매는 길이 2.5mm 정도로 방추형이다. 뿌리를 생으로 먹을 수 있으나 머리카락이 타는 냄새가 난다. 한국, 일본(남부), 중국 북동부 등지에 분포한다. The fruit is fusiform with a length of 2.5 mm. The roots can be eaten raw, but the hair smells like burning. It is distributed in Korea, Japan (southern), and northeastern China.

이러한 갯질경은 바닷물이 드나드는 갯벌과 소금기가 많은 토양에서 자라는 염색식물로, 잎과 뿌리에는 강력한 항산화 물질인 카테킨을 비롯한 플라보노이드의 일종인 미리세틴(myricetin) 등이 고농도로 함유되어 있다.Psyllium is a dyed plant that grows in tidal flats and salty soils where seawater flows. The leaves and roots contain catechin, a powerful antioxidant, and myricetin, a kind of flavonoid, in high concentrations.

이러한 갯질경은 농촌진흥청이 게재한 Natural product sciendes, 2015년 3월호에 의하면, 갯질경을 먹인 쥐는 알코올만 먹인 쥐보다 혈중 알코올 농도가 5.34±0.38nM에서 2.41±0.36nM으로 55% 빠르게 감소한 정도로, 혈중 콜레스테롤의 정상화와 간 조직 내 중성지질의 감소에 효과가 있다고 알려져 있다.According to the March 2015 issue of Natural product sciendes published by the Rural Development Administration, the blood alcohol concentration of rats fed psyllium was reduced by 55% faster from 5.34±0.38nM to 2.41±0.36nM in rats fed only alcohol. It is known to be effective in normalizing blood cholesterol and reducing triglycerides in liver tissue.

한편, 항산화 및 항염증에 대한 효능을 가지는 조성물로서 다양한 조성물이 있으며, 이 중에서 지채, 비쑥 및 홍삼을 소개하고자 한다.On the other hand, there are various compositions as compositions having antioxidant and anti-inflammatory effects, and among them, we would like to introduce Jichae, wormwood, and red ginseng.

지채(Triglochin maritimum)는, 외떡잎식물 소생식물목 지채과의 여러해살이풀로서, 갯벌이나 바닷가에서 무리지어 자란다. 뿌리줄기는 굵고 짧으며 튼튼한 뿌리가나오고 오래 된 잎자루에서 남은 섬유가 겉을 덮고 있다. 꽃줄기는 곧게 서고가지가 갈라지지 않으며 높이가 15∼40cm이다. Jichae ( Triglochin maritimum ) is a monocotyledonous prophylactic plant, a perennial herb of the family Brassicaaceae, which grows in groups on the tidal flats or on the seashore. The rhizome is thick, short, and has strong roots, and the fibers remaining from the old petiole cover the outside. Flower stalks stand upright, do not branch, and are 15-40 cm in height.

잎은 뿌리에서 모여 나오고 줄 모양이며 길이가 10∼30cm, 폭이 2∼4mm이고 끝이둔하며 밑 부분이 잎집이 된다. 잎집은 흰색의 막질(膜質:얇은 종이처럼 반투명한것)이고 끝에 길이 3∼5mm의 잎혀가 있다. The leaves are gathered from the root and are line-shaped, 10-30cm long and 2-4mm wide, with a dull tip, and the lower part becomes the sheath. The sheath is white membranous (膜質: translucent like thin paper) and has a leaf tongue with a length of 3~5mm at the tip.

꽃은 8∼9월에 자줏빛이 도는 녹색으로 피고 잎 사이에서 나온 꽃줄기 끝에 수상꽃차례를 이루며 달린다. 작은꽃자루는 길이가 2∼4mm이고, 꽃잎은 6개이며타원 모양이고 2줄로 달린다. 수술은 6개이고 수술대는 없으며, 암술은 암술대가매우 짧고 암술머리가 6개이다. Flowers bloom in August-September in purplish-green, and run in stellate inflorescences at the end of stalks that emerge from between the leaves. Small peduncle is 2~4mm long, and has 6 petals, oval shape, and runs in 2 lines. There are 6 stamens and there is no operating table, and the pistil has a very short style and has 6 stigma heads.

한방에서는 지채의 뿌리줄기를 포함한 전초를 말린 것을 지채라 하여 과실을 함께 약용하는데, 과실은 몸의 영양을 보하는 보자, 설사를 멈추게하는 지사, 통증을 멈추게하는 지통의 효능을 가지며, 눈이 아픈 목통을 다스리고, 뿌리를 포함한 전초는 열기를 식히고 열로 인해 고갈된 음액을 보충하여 회복시키는 청열양음과 몸안의 액체, 즉 체액을 생기게하는 생진액, 갈증을 멈추게 하는 지갈의 효능이 있다.In oriental medicine, dried outplants including the rhizomes of ajichae are called ajichae, and the fruits are used together. It treats neck pain, and the outpost including roots cools the heat and replenishes and restores the yin liquid depleted due to heat.

비쑥(Artemisia scoparia Waldst. et Kit.)은, 쑥속(Artemisia) 식물로서, 봄철에 채집한 것을 ‘면인진(綿茵陳)’이라 칭하고, 가을철에 채집한 것을 ‘인진호(茵陳蒿)’라고 칭한다. Artemisia scoparia Waldst. et Kit. ) is a plant of the genus Artemisia, and the one collected in spring is called 'Myeoninjin (綿茵陳)', and the one collected in autumn is called 'Injinho (茵陳蒿)'. call it

비쑥의 ‘인진호’란 약명은 《신농본초경(神農本草經)》에 상품으로 처음 기재되었으며 역대 본초서적에 대부분 기록되었다. 중국에서 전통적으로 사용되는 것은 이 종과 사철쑥(茵陳蒿, Artemisia capillaris Thunb.)이다. 《중국약전(中國藥典)》(2015년 판)에서는 이 종을 중약 인진의 법정기원식물로 수록하였다. 주요산지는 중국의 섬서, 하북 등지이다. 섬서에서 나는 것을 서인진(西茵陳)이라 부르는데 품질이 가장 우수하다. 《대한민국약전외한약(생약)규격집》(제4개정판)에는 인진호를 “사철쑥(Artemisia capillaris Thunberg, 국화과)의 지상부이다. 봄에 채취한 것을 ‘면인진’이라 하고, 가을에 채취한 것을 ‘인진호’라 한다”로 등재하고 있다. The abbreviation of 'Injinho' of bi-wormwood was first described as a product in the 『Shinnong Bonchogyeong (神農本草經)』, and most of the history books were recorded. Traditionally used in China is this species and Artemisia capillaris Thunb. In the Chinese Pharmacopoeia (Chinese Pharmacopoeia (Chinese Pharmacopoeia) (2015 edition)), this species was listed as a plant of legal origin for Chinese medicine Injin. The main production areas are Shaanxi and Hebei in China. The one from Shaanxi is called Seoinjin (西茵陳), and the quality is the best. In the <Korean Pharmacopoeia and Other Herbal Medicines Specifications> (4th edition), Injinho is referred to as “the above-ground part of Artemisia capillaris Thunberg (Asteraceae). Those harvested in spring are called 'Myeoninjin', and those harvested in autumn are called 'injinho'.”

비쑥의 유효성분으로는 주로 정유, 쿠마린, 플라보노이드, 크로몬 화합물 등을 함유하고 있다. 그중 여러 가지 성분은 보간이담(保肝利膽)의 활성이 있다. 《중국약전》에서는 고속액체크로마토그래피법을 이용하여 클로로겐산의 함량을 0.50% 이상, 스코파론의 함량을 0.20% 이상으로 약재의 규격을 정하고 있다. As the active ingredients of wormwood, it mainly contains essential oils, coumarins, flavonoids, and chromone compounds. Among them, several components have the activity of interpolation idam (保肝利膽). In "Chinese Pharmacopoeia", using high-performance liquid chromatography, the content of chlorogenic acid is 0.50% or more, and the content of scoparone is 0.20% or more, and the specifications of medicinal materials are set.

약리연구를 통하여 비쑥에는 이담보간(利膽保肝), 소염, 진통, 이뇨, 항혈압, 항종양 등의 작용이 있는 것으로 알려져 있다.Through pharmacological studies, it is known that wormwood has anti-inflammatory, anti-inflammatory, analgesic, diuretic, anti-hypertensive, and anti-tumor effects.

한의학에서 인진은 청열이습(淸熱利濕), 이담퇴황(利膽退黃) 등의 효능이 있다.In oriental medicine, ginseng has effects such as relieving fever and relieving fever.

홍삼은 한약의 일종으로, 두릅나무과에 속하는 인삼(Panax ginseng CA Meyer)의 뿌리를 증기로 찐 것으로 배당체, 인삼향성분, 항산화물질, 유기산 등이 함유되어 있으며 암세포의 성장을 억제하고 암발생을 예방하며, 노화예방과 피로회복, 숙취제거, 혈액순환 등에 효능이 있다. 또한 홍삼에 함유되어 있는 사포닌 성분은 당뇨 유발물질인 알록산과 스트렙토조토신을 제거해주어 당뇨에 효능이 있는 것으로 알려져 있다.Red ginseng is a type of herbal medicine that is steamed from the roots of Panax ginseng CA Meyer belonging to the Araliaceae family. It contains glycosides, ginseng flavoring ingredients, antioxidants, organic acids, etc. It is effective in preventing aging, recovering from fatigue, removing hangovers, and improving blood circulation. In addition, the saponin component contained in red ginseng is known to be effective in diabetes by removing alloxane and streptozotocin, which are substances that cause diabetes.

사포닌(Saponin)은 콩, 파, 더덕, 메밀, 도라지 등 다양한 식물에 소량 함유되어 있지만 홍삼에 함유되어 있는 사포닌은 약성이 온화하고 독성이 없을 뿐만 아니라 용혈 작용이 거의 없으며 타 식물에서 발견되는 사포닌과 화학구조가 전혀 다르다. 따라서 홍삼에 함유되어 있는 사포닌은 다른 식물계 사포닌과 구별하기 위해 진세노사이드(Ginsenoside)라고 부른다.Saponin is contained in small amounts in various plants such as soybean, green onion, deodeok, buckwheat, and bellflower. The chemical structure is completely different. Therefore, the saponins contained in red ginseng are called ginsenosides to distinguish them from other plant-based saponins.

진세노사이드는 미량에 의해서도 강한 약리효과를 나타내는 것으로 보고되고 있는데 주요 약리작용은 중추신경계를 비롯하여, 내분비계, 면역계, 대사계 등에 영향을 미쳐 신체조절기능에 다양한 효과를 발휘하는 것으로 알려져 있다.It is reported that ginsenosides show strong pharmacological effects even in small amounts, and the main pharmacological effects are known to exert various effects on body control functions by affecting the central nervous system, endocrine system, immune system, and metabolic system.

본 출원인은 상술된 효능을 기반으로 UV-B(ultraviolet-B) 등에 의해 콜라겐 또는 엘라스틴 등이 손상된 피부세포를 재생할 수 있는 조성물을 제안하고자 한다.The present applicant intends to propose a composition capable of regenerating damaged skin cells such as collagen or elastin by UV-B (ultraviolet-B), etc., based on the above-described efficacy.

피부 세포 재생에 관련하여, 등록특허공보 제10-1652956호에는 항산화 기능 및 세포 증식 효과가 증가된 인간 상피세포재생인자 융합단백질 및 이를 유효성분으로 함유하는 피부 주름 개선 및 항노화 화장료 조성물이 기재되어 있다.With respect to skin cell regeneration, Patent Publication No. 10-1652956 discloses a human epithelial cell regeneration factor fusion protein with increased antioxidant function and cell proliferation effect and a skin wrinkle improvement and anti-aging cosmetic composition containing the same as an active ingredient. have.

등록특허공보 제10-1652956호(2016.08.31. 공고)Registered Patent Publication No. 10-1652956 (2016.08.31. Announcement)

본 발명의 목적은, 갯질경을 유효성분으로 포함하는 피부세포재생용 조성물을 제공하는데 있다.It is an object of the present invention to provide a composition for skin cell regeneration comprising phyllotaxis as an active ingredient.

본 발명은 갯질경을 유효성분으로 함유하는 피부세포재생용 조성물로서,The present invention relates to a composition for skin cell regeneration containing Psyllium as an active ingredient,

상기 조성물은,The composition is

갯질경, 지채, 비쑥 및 홍삼을 이용한 추출물이고,It is an extract using sagebrush, lichen, wormwood, and red ginseng.

갯질경 : 지채 : 비쑥 : 홍삼의 비율을 2 : 1 : 1 : 2의 비율로 하되,The ratio of gaejigyeong: jichae: mugwort: red ginseng is 2 : 1 : 1 : 2,

상기 비율을 100g으로 정량하여, 50%(v/v) 에탄올 2L를 넣어 실온에서 5일 동안 추출함으로써 혼합추출물을 획득하며,The ratio is quantified as 100 g, and a mixed extract is obtained by adding 2 L of 50% (v/v) ethanol and extracting at room temperature for 5 days,

상기 혼합추출물을 여과한 후, 감압농축기를 통해 농축하고, 동결건조기를 통해 건조하여 회수한 뒤, -20℃에 보관함으로써 획득된 복합추출물인 것을 특징으로 한다.After filtering the mixed extract, it is characterized in that it is a complex extract obtained by concentrating through a vacuum concentrator, drying through a freeze dryer to recover, and storing at -20°C.

이때, 상기 조성물은,At this time, the composition,

100㎍/㎖ 이하의 농도에서는, 인간 유래 HaCat 세포의 생존율에 영향을 미치지 않는 것을 특징으로 하고,At a concentration of 100 μg/ml or less, it is characterized in that it does not affect the viability of human-derived HaCat cells,

인간 유래 HaCaT 세포의 배양액에 100㎍/㎖의 농도로 처리하였을 때, 과산화물에 의한 세포손상시 복합추출물의 무첨가군 대비 높은 재생률을 가지는 것을 특징으로 하며,When the human-derived HaCaT cell culture solution is treated at a concentration of 100 μg/ml, it is characterized in that it has a higher regeneration rate compared to the group without the addition of the complex extract when cells are damaged by peroxide,

인간 유래 HaCaT 세포의 배양액에 100㎍/㎖의 농도로 처리하였을 때, UV-B에 의한 콜라겐 손상으로부터 콜라겐 재생률이, 복합추출물의 무첨가군 대비 높은 재생률을 가지는 것을 특징으로 하고,When the culture solution of human-derived HaCaT cells was treated at a concentration of 100 μg/ml, the collagen regeneration rate from collagen damage caused by UV-B was characterized in that it had a higher regeneration rate compared to the group without the addition of the complex extract,

인간 유래 HaCaT 세포의 배양액에 100㎍/㎖의 농도로 처리하였을 때, 인간 유래 HaCaT 세포에서 UV-B에 의한 콜라겐 손상으로부터 콜라겐 재생율이 증가하는 것을 특징으로 하며,When the human-derived HaCaT cell culture solution is treated at a concentration of 100 μg/ml, the collagen regeneration rate from UV-B-induced collagen damage in human-derived HaCaT cells is increased.

인간 유래 HaCaT 세포의 배양액에 100㎍/㎖의 농도로 처리하였을 때, 인간 유래 HaCaT 세포에서 UV-B에 의한 콜라겐 손상으로부터 엘라스틴과 콜라겐 단백질의 생성량이 증가하는 것을 특징으로 하고,When the human-derived HaCaT cell culture solution is treated at a concentration of 100 μg/ml, the production amount of elastin and collagen protein increases from UV-B-induced collagen damage in human HaCaT cells,

UV-B에 의한 피부손상으로부터 표피부종 감소, 비만세포의 침윤 억제 및 피부 콜라겐 보호 효과를 가지는 것을 특징으로 한다.It is characterized in that it has the effect of reducing epidermis from skin damage caused by UV-B, inhibiting infiltration of mast cells, and protecting skin collagen.

특히, 본 발명에 따른 조성물은 비타민 C를 참가하는 경우, 콜라겐 합성률이 증가하는 것을 특징으로 한다.In particular, the composition according to the present invention is characterized in that when vitamin C is added, the collagen synthesis rate is increased.

본 발명에 따른 갯질경을 유효성분으로 포함하는 피부세포재생용 조성물에 의하면, 갯질경, 지채, 비쑥 및 홍삼의 유효성분을 함유하는 추출물에 기반한 피부세포재생용 조성물을 제공할 수 있다.According to the composition for skin cell regeneration comprising phyllophthora as an active ingredient according to the present invention, it is possible to provide a composition for skin cell regeneration based on an extract containing the active ingredients of phyllophyllum basilica, sagebrush and red ginseng.

도 1은 실험예 1에 따른 세포배양 실험의 결과를 나타낸 것이다.
도 2 및 도 3은 실험예 2에 따른 세포배양 실험의 결과를 나타낸 것으로서, 도 2는 과산화물에 의한 세포손상으로부터 재생률을 확인한 것이고, 도 3은 UV-B에 의한 콜라겐 손상으로부터 콜라겐 재생률을 ELISA Kit를 통해 배양액으로 방출된 콜라겐의 양을 확인한 결과를 확인한 것이다.
도 4는 실험예 3에 따른 실험결과를 나타낸 것이다.
도 5는 실험예 4에 따른 결과를 나타낸 것이다.
도 6은 실험예 5에 따른 결과를 나타낸 것이다.
도 7은 실험예 5에 따른 결과의 확인을 위하여 조직학적 분석을 수행한 것이다.
도 8은 실험예 6에 따른 결과를 나타낸 것이다.
도 9는 실험예 7에 따른 결과를 나타낸 것이다.
1 shows the results of a cell culture experiment according to Experimental Example 1.
2 and 3 show the results of the cell culture experiment according to Experimental Example 2, FIG. 2 shows the confirmation of the regeneration rate from cell damage caused by peroxide, and FIG. 3 shows the collagen regeneration rate from the collagen damage caused by UV-B ELISA Kit The result of confirming the amount of collagen released into the culture medium was confirmed.
4 shows the experimental results according to Experimental Example 3.
5 shows the results according to Experimental Example 4.
6 shows the results according to Experimental Example 5.
7 is a histological analysis performed to confirm the results according to Experimental Example 5.
8 shows the results according to Experimental Example 6.
9 shows the results according to Experimental Example 7.

본 명세서 및 청구범위에 사용된 용어나 단어는 통상적이거나 사전적인 의미로 한정해서 해석되어서는 안되며, 발명자는 그 자신의 발명을 가장 최선의 방법으로 설명하기 위해 용어의 개념을 적절하게 정의할 수 있다는 원칙에 입각하여 본 발명의 기술적 사상에 부합하는 의미와 개념으로 해석되어야만 한다.The terms or words used in the present specification and claims should not be construed as being limited to their ordinary or dictionary meanings, and the inventor may properly define the concepts of the terms to best describe his invention. Based on the principle, it should be interpreted as meaning and concept consistent with the technical idea of the present invention.

따라서 본 명세서에 기재된 실시 예와 도면에 도시된 구성은 본 발명의 가장 바람직한 실시 예에 불과할 뿐이고 본 발명의 기술적 사상을 모두 대변하는 것은 아니므로, 본 출원시점에 있어서 이들을 대체할 수 있는 다양한 균등물과 변형 예들이 있을 수 있음을 이해하여야 한다.Therefore, the embodiments described in this specification and the configurations shown in the drawings are only the most preferred embodiments of the present invention and do not represent all the technical spirit of the present invention, so various equivalents that can be substituted for them at the time of the present application It should be understood that there may be variations and examples.

이하, 도면을 참조하여 설명하기에 앞서, 본 발명의 요지를 드러내기 위해서 필요하지 않은 사항 즉 통상의 지식을 가진 당업자가 자명하게 부가할 수 있는 공지 구성에 대해서는 도시하지 않거나, 구체적으로 기술하지 않았음을 밝혀둔다.Hereinafter, prior to the description with reference to the drawings, it is not shown or specifically described for the known configurations that are not necessary to reveal the gist of the present invention, that is, those skilled in the art that can be added obviously by those skilled in the art. reveal the sound

본 발명은 갯질경을 유효성분으로 포함하는 피부세포재생용 조성물에 관한 것이다.The present invention relates to a composition for regenerating skin cells, which includes P.

이러한 본 발명에 따른 피부세포재생용 조성물은 갯질경, 지채, 비쑥 및 홍삼을 주요 조성물로 하며, 바람직하게는 갯질경 : 지채 : 비쑥 : 홍삼의 비율을 2 : 1 : 1 : 2의 비율로 하고,The composition for skin cell regeneration according to the present invention includes, as the main composition, sagebrush, sagebrush, sagebrush and red ginseng, and preferably, the ratio of sagebrush: sagebrush: sagebrush: red ginseng is 2 : 1 : 1 : 2, ,

상기 비율로 무게비 100g으로 정량하여, 50%(v/v) 에탄올 2L를 넣어 실온에서 5일 동안 추출하여 혼합추출물을 획득하도록 한다.Quantify at a weight ratio of 100 g in the above ratio, add 2 L of 50% (v/v) ethanol, and extract at room temperature for 5 days to obtain a mixed extract.

이때, 혼합추출물을 Advantec filter paper No. 2(Toyo Roshi Kaisha, Tokyo, Japan)를 사용하여 여과하고 감압농축기(EYELA, Tokyo, Japan)에서 농축한 다음 동결건조기(EYELA FDU- 2100, EYELA)에서 건조하여 회수한 후 -20℃에 보관함으로써 복합추출물을 획득하도록 하였다.At this time, the mixed extract was applied to Advantec filter paper No. 2 (Toyo Roshi Kaisha, Tokyo, Japan), concentrated in a vacuum concentrator (EYELA, Tokyo, Japan), dried in a freeze dryer (EYELA FDU-2100, EYELA), recovered and stored at -20℃ A complex extract was obtained.

다만, 위 복합추출물을 획득하는 과정에서의 조건들은 본 발명에 제한되는 것은 아니다. 즉, 혼합추출물을 획득하는 조건과 획득된 혼합추출물을 여과한 후 농축하여 건조 및 회수를 통해 -20℃의 온도에서 보관하는 조건만 갖출 수 있다면 그 외의 조건은 제한없이 적용될 수 있는 것이다.However, the conditions in the process of obtaining the above complex extract are not limited to the present invention. That is, if only the conditions for obtaining the mixed extract and the conditions for filtering the obtained mixed extract and then storing it at a temperature of -20°C through drying and recovery can be met, other conditions can be applied without limitation.

본 발명의 일 구현 예에 따른 조성물은, 스킨, 스킨 소프트너, 스킨 토너, 아스트린젠트, 로션, 밀크로션, 모이스쳐로션, 영양로션, 마사지크림, 영양크림, 아이크림, 모이스쳐 크림, 핸드크림, 에센스, 영양에센스, 팩, 클렌징 폼, 클렌징 워터, 클렌징 로션, 클렌징 크림, 바디로션, 바디클렌져, 비누 및 파우더로 이루어진 군으로부터 선택되는 어느 하나의 제형을 가질 수 있으나, 이에 제한되지 않는다. 이들 각 제형으로 이루어진 조성물은 그 제형의 제제화에 필요하고 적절한 각종의 기제와 첨가물을 함유할 수 있으며, 이들 성분의 종류와 양은 당업자에 의해 용이하게 선정될 수 있다.The composition according to an embodiment of the present invention includes skin, skin softener, skin toner, astringent, lotion, milk lotion, moisture lotion, nourishing lotion, massage cream, nourishing cream, eye cream, moisture cream, hand cream, essence, It may have any one formulation selected from the group consisting of nutritional essence, pack, cleansing foam, cleansing water, cleansing lotion, cleansing cream, body lotion, body cleanser, soap and powder, but is not limited thereto. The composition consisting of each of these formulations may contain various bases and additives necessary and appropriate for the formulation of the formulation, and the types and amounts of these components can be easily selected by those skilled in the art.

본 발명의 다른 구현 예에 따른 조성물은 경구투여를 목적으로 하는 기능식품으로 가공될 수도 있다.The composition according to another embodiment of the present invention may be processed into a nutraceutical for oral administration.

이때, 기능식품에 특별한 제한은 없다. 상술된 조성물을 첨가할 수 있는 식품의 예로는 육류, 소시지, 빵, 초콜릿, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차 드링크제, 알콜 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 건강식품을 모두 포함한다.At this time, there is no particular limitation on the functional food. Examples of foods to which the above-described composition can be added include meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gums, dairy products including ice cream, various soups, beverages, tea drinks, There are alcoholic beverages, vitamin complexes, and the like, and includes all health foods in the ordinary sense.

이하, 본 발명의 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.Hereinafter, an embodiment of the present invention will be described in detail. However, the following examples are merely illustrative of the present invention, and the content of the present invention is not limited to the following examples.

실험재료experimental material

Dulbecoos modified Eagle's medium (DMEM), fetal bovine serum (FBS)과 RIPA buffer는 Invitrogen사 (Waltham, MA, USA)에서 구입하였다. EZ-Cytox는 Dogenbio사 (Seoul, Korea)에서 구입하였다.Dulbecoos modified Eagle's medium (DMEM), fetal bovine serum (FBS) and RIPA buffer were purchased from Invitrogen (Waltham, MA, USA). EZ-Cytox was purchased from Dogenbio (Seoul, Korea).

type1 collagen 및 elastin 항체와 이차 항체는 Santa Cruz Biotechnology사(Santa Cruz, CA, USA)에서 구입하였다. β-actin 항체는 BD Biosciences사 (CA, USA)에서 구입하였다.Type1 collagen and elastin antibodies and secondary antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). β-actin antibody was purchased from BD Biosciences (CA, USA).

제조예 1. 피부세포재생용 조성물Preparation Example 1. Composition for skin cell regeneration

본 발명에 사용된 염생식물은 새만금 및 고창군 갯벌에서 채취한 후 실험에 사용 하였다. 각각의 식물을 갯질경 2: 지채 1: 비쑥 1: 홍삼 2의 비율로 100g 정량 후 50%에탄올 2L를 넣고 실온에서 5일동안 추출하여 혼합추출물을 획득하였다.The halophytes used in the present invention were collected from the tidal flats of Saemangeum and Gochang-gun, and then used in the experiment. After quantifying 100 g of each plant in the ratio of sphagnum 2: fern 1: mugwort 1: red ginseng 2, 2L of 50% ethanol was added, and extracted for 5 days at room temperature to obtain a mixed extract.

상기 혼합추출물을 Advantec filter paper No. 2(Toyo Roshi Kaisha, Tokyo, Japan)를 사용하여 여과하고 감압농축기(EYELA, Tokyo, Japan)에서 농축한 다음 동결건조기(EYELA FDU- 2100, EYELA)에서 건조하여 회수한 후 -20℃에 보관하여 복합추출물을 획득하였다.The mixed extract was prepared using Advantec filter paper No. 2 (Toyo Roshi Kaisha, Tokyo, Japan), concentrated in a vacuum concentrator (EYELA, Tokyo, Japan), dried in a freeze dryer (EYELA FDU-2100, EYELA), recovered and stored at -20℃ A complex extract was obtained.

실험예 1. 세포배양 실험Experimental Example 1. Cell culture experiment

HaCaT 세포주는 American Type Culture Collection (ATCC, Rockville, MD, USA)사 로부터 구입하여 사용하였다.The HaCaT cell line was purchased from the American Type Culture Collection (ATCC, Rockville, MD, USA) and used.

B16/F10 세포와 HaCaT 세포는 10% FBS와 1% antibiotics (penicillin & streptomycin)가 함유된 DMEM배지를 사용하여 습도가 충분하고 37℃가 유지되는 5% CO2 배양기에서 배양 하였다. B16/F10 cells and HaCaT cells were cultured using DMEM medium containing 10% FBS and 1% antibiotics (penicillin & streptomycin) in a 5% CO2 incubator maintained at 37°C with sufficient humidity.

해당 실험에 따른 결과는 첨부된 도면의 도 1을 참조할 수 있다.The results according to the experiment may be referred to FIG. 1 of the accompanying drawings.

도 1은 실험예 1에 따른 세포배양 실험의 결과를 나타낸 것이다.1 shows the results of a cell culture experiment according to Experimental Example 1.

첨부된 도면의 도 1에 따르면, 인간 유래 HaCat 세포에서는 위 제조예 1에 따른 복합추출물 25~400㎍/㎖의 농도까지 세포독성을 확인한 결과, 100㎍/㎖ 이하에서는 세포생존율에 영향을 미치지 않았음을 확인할 수 있었다.According to FIG. 1 of the accompanying drawings, as a result of confirming cytotoxicity in human-derived HaCat cells up to a concentration of 25 to 400 μg/ml of the complex extract according to Preparation Example 1, the cell viability was not affected at 100 μg/ml or less. sound could be confirmed.

실험예 2. 세포독성 평가Experimental Example 2. Cytotoxicity evaluation

HaCaT 세포를 각각 96 well plates에 2×105 cells/ml의 농도로 분주하여 배양한 후 농도별로 정량한 각각의 복합추출물을 주입한 후 20시간 동안 배양한 후 EZ-Cytox 10㎍ 주입 후 4시간뒤 450nm에서 흡광도를 측정하였다. 생존율은 복합추출물의 무첨가군 대비 백분율로 계산하였다.HaCaT cells were dispensed into 96 well plates at a concentration of 2×10 5 cells/ml and cultured, and each complex extract quantified by concentration was injected and cultured for 20 hours. Absorbance was then measured at 450 nm. The survival rate was calculated as a percentage compared to the non-additive group of the complex extract.

해당 실험에 따른 결과는 첨부된 도면의 도 2 및 도 3을 참조할 수 있다.Results according to the experiment may be referred to FIGS. 2 and 3 of the accompanying drawings.

도 2 및 도 3은 실험예 2에 따른 세포배양 실험의 결과를 나타낸 것으로서, 도 2는 과산화물에 의한 세포손상으로부터 재생률을 확인한 것이고, 도 3은 UV-B에 의한 콜라겐 손상으로부터 콜라겐 재생률을 ELISA Kit를 통해 배양액으로 방출된 콜라겐의 양을 확인한 결과를 확인한 것이다.2 and 3 show the results of the cell culture experiment according to Experimental Example 2, FIG. 2 shows the confirmation of the regeneration rate from cell damage caused by peroxide, and FIG. 3 shows the collagen regeneration rate from the collagen damage caused by UV-B ELISA Kit. The result of confirming the amount of collagen released into the culture medium was confirmed.

첨부된 도면의 도 2에 따르면, 인간 유래 HaCat 세포에서는 과산화물에 의해 세포손상으로부터 재생률을 확인한 결과, 제조예 1에 따른 복합추출물을 세포배양액에 100㎍/㎖의 농도로 처리하였을 때, 양성대조군 대비 약 25% 이상의 재생률을 보여 세포 재생 효과가 있었음을 확인하였다.According to FIG. 2 of the accompanying drawings, as a result of confirming the regeneration rate from cell damage by peroxide in human-derived HaCat cells, when the complex extract according to Preparation Example 1 was treated at a concentration of 100 μg/ml in the cell culture medium, compared to the positive control group It was confirmed that there was a cell regeneration effect by showing a regeneration rate of about 25% or more.

또한, 첨부된 도면의 도 3에 따르면, 인간 유래 HaCat 세포에서 UV-B에 의한 콜라겐 손상으로부터 콜라겐 재생률을 ELISA-Kit를 통해 배양액으로 방출된 콜라겐의 양을 확인한 결과, 추출물을 배양액에 100㎍/㎖의 농도로 처리하였을 때, 양성대조군 대비 약 28% 이상의 생성양을 보여 콜라겐 생성증가 효과가 있었음을 확인하였다.In addition, according to FIG. 3 of the accompanying drawings, the collagen regeneration rate from UV-B-induced collagen damage in human-derived HaCat cells was confirmed by ELISA-Kit to determine the amount of collagen released into the culture medium. When treated at a concentration of ㎖, it was confirmed that there was an effect of increasing collagen production by showing a production amount of about 28% or more compared to the positive control group.

실험예 3. 면역형광염색Experimental Example 3. Immunofluorescence staining

HaCaT세포를 slide glass에 2×105 cells/ml의 농도로 분주하여 24시간 배양한 후 각각의 추출물을 100㎍/㎖의 농도로 주입 후 1시간뒤 UV-B(20 mJ/cm2)조사 후 24시간 배양한 후 세포를 methanol로 고정한 뒤 1% BSA가 함유된 PBS로 blocking한 뒤 collagenI 항체를 주입 후 4℃에서 16시간 반응 시켰다.HaCaT cells were dispensed on a slide glass at a concentration of 2×10 5 cells/ml and cultured for 24 hours. Each extract was injected at a concentration of 100 μg/ml, followed by UV-B (20 mJ/cm 2 ) irradiation 1 hour later. After incubation for 24 hours, the cells were fixed with methanol, blocked with PBS containing 1% BSA, injected with collagenI antibody, and reacted at 4°C for 16 hours.

PBST로 10분간 3회 세척 후 2차 항체로 Goat anti-Rabbit IgG Alexa Fluor 488를 사용하여 반응 시킨 후 DAPI가 포함된 mounting 용액으로 mounting 하였다. slide 24시간 건조 후 형광현미경을 사용하여 이미지를 얻었다.After washing 3 times for 10 minutes with PBST, the secondary antibody was reacted with Goat anti-Rabbit IgG Alexa Fluor 488, followed by mounting with a mounting solution containing DAPI. After drying the slide for 24 hours, images were obtained using a fluorescence microscope.

이는 첨부된 도면의 도 4를 참조하도록 한다.This will refer to FIG. 4 of the accompanying drawings.

도 4는 실험예 3에 따른 실험결과를 나타낸 것이다.4 shows the experimental results according to Experimental Example 3.

첨부된 도면의 도 4에 따르면, 인간 유래 HaCaT 세포에서 UV-B에 의한 콜라겐 손상으로부터 콜라겐 재생율을 면역형광염색을 통해 확인한 결과, 제조예 1에 따른 복합추출물을 세포배양액에 100㎍/㎖의 농도로 처리하였을 때, 콜라겐 합성률이 증가하는 것을 확인하였다.According to FIG. 4 of the accompanying drawings, as a result of confirming the collagen regeneration rate from UV-B-induced collagen damage in human-derived HaCaT cells through immunofluorescence staining, the complex extract according to Preparation Example 1 was added to the cell culture medium at a concentration of 100 μg/ml. When treated with , it was confirmed that the collagen synthesis rate increased.

실험예 4. Western blot analysisExperimental Example 4. Western blot analysis

HaCaT 세포를 6well plates에 2×105 cells/ml의 농도로 분주하여 24시간 배양한 후 각각의 추출물을 100 μg/ml의 농도로 주입 후 1시간뒤 UVB(20 mJ/cm2)조사 후 24시간 배양한 후 세포를 PBS로 2회 원심세척 후 RIPA buffer를 주입 후 12,000RPM으로 원심분리 하여 단백질을 추출하였다.HaCaT cells were dispensed on 6 well plates at a concentration of 2×10 5 cells/ml and cultured for 24 hours. After each extract was injected at a concentration of 100 μg/ml, 1 hour after UVB (20 mJ/cm 2 ) irradiation, 24 After culturing for time, the cells were centrifuged twice with PBS, injected with RIPA buffer, and centrifuged at 12,000 RPM to extract proteins.

추출한 단백질은 Bradford protein assay reagent를 사용하여 595nm에서 흡광도를 측정하여 정량하였다. 정량한 단백질을 SDS-PAGE를 통해 분리 후 100V로 1시간동안 PVDF (polyvinylidene difluoride) membrane (Bio-Rad)에 transfer하였다. Membrane은 5% BSA가 함유된 Tris buffered saline with 1% Tween20(TBST)에 실온에서 blocking후 TBST로 10분간 3회 세척후 1차항체로 anti-MMP1, anti-collagenI, anti-β-actin을 사용 하여 4℃ 16시간 반응 시켰다.The extracted protein was quantified by measuring absorbance at 595 nm using Bradford protein assay reagent. The quantified protein was separated through SDS-PAGE and transferred to PVDF (polyvinylidene difluoride) membrane (Bio-Rad) at 100V for 1 hour. Membrane was blocked in Tris buffered saline with 1% Tween20 (TBST) containing 5% BSA at room temperature and washed 3 times with TBST for 10 minutes. and reacted at 4°C for 16 hours.

그 후, TBST로 10분간 3회 세척 후 2차항체 (goat anti-rabbit IgG HRP, rabbit anti-mouse IgG HRP)를 5% BSA에서 실온에서 2시간 반응 후 TBST로 10분간 3회 세척 후 하였다.Then, after washing 3 times with TBST for 10 minutes, secondary antibodies (goat anti-rabbit IgG HRP, rabbit anti-mouse IgG HRP) were reacted in 5% BSA at room temperature for 2 hours, and then washed 3 times with TBST for 10 minutes.

이는 첨부된 도면의 도 5를 첨부하여 결과를 확인하도록 한다.This is to confirm the result by attaching FIG. 5 of the accompanying drawings.

도 5는 실험예 4에 따른 결과를 나타낸 것이다.5 shows the results according to Experimental Example 4.

도 5는 인간 유래 HaCaT 세포에서 UV-B에 의한 콜라겐 손상으로부터 세포 내 엘라스틴과 콜라겐 단백질 발현을 알아보기 위하여 이들 분자에 특이적으로 작용하는 항체를 활용하여 Western blot로 확인한 결과로서, 두 단백질 모두 추출물을 세포배양액에 100㎍/㎖의 농도로 처리하였을 때, 생성량이 증가하는 것을 확인할 수 있었다.Figure 5 is the result confirmed by Western blot using an antibody that specifically acts on these molecules to examine the intracellular elastin and collagen protein expression from UV-B-induced collagen damage in human-derived HaCaT cells, both proteins extract When the cell culture medium was treated at a concentration of 100 μg/ml, it was confirmed that the production amount increased.

실험예 5. 동물실험Experimental Example 5. Animal Experiment

무균환경에서 사육된 7주령의 수컷 C57/BL과 ICR 마우스는 오리엔트바이오사(익산, 대한민국)에서 구입하였고, 사료와 물을 충분히 공급하면서 1주일 간 순화시킨 후 실험에 사용하였다.7-week-old male C57/BL and ICR mice bred in a sterile environment were purchased from Orient Bio (Iksan, Korea), and were acclimatized for 1 week while sufficiently supplied with feed and water, and then used in the experiment.

사육환경은 낮과 밤의 주기를 12시간씩 하였고, 온도 (20~22℃)와 습도 (50~60%)는 일정하게 유지하였다. 그 후 매일 추출물을 200mg/kg 농도로 제조예 1에 따른 복합추출물을 경구투여 하면서 3일 간격으로 UVB(300mJ/cm2)를 조사 하였다. 2주동안 실험을 진행 후 각각의 분석법에 따라 결과를 분석하였다.The breeding environment had a day and night cycle of 12 hours each, and the temperature (20~22℃) and humidity (50~60%) were kept constant. After that, UVB (300mJ/cm 2 ) was irradiated every 3 days while orally administering the complex extract according to Preparation Example 1 at a concentration of 200 mg/kg of the extract every day. After conducting the experiment for 2 weeks, the results were analyzed according to each analysis method.

실험 최종일인 14일째 마우스를 희생시키고 피부조직을 절취하여 10% 중성 포르말린(pH 7.4)으로 24시간 고정 한 후 50~100% 에탄올을 사용하여 탈수하고 xylene으로 세척하는 등 일련의 과정을 거쳐 파라핀메몰표본을 제작 하였다On the 14th day, the last day of the experiment, the mice were sacrificed, the skin tissue was cut out, fixed with 10% neutral formalin (pH 7.4) for 24 hours, dehydrated using 50-100% ethanol, washed with xylene, etc. samples were made

제작된 각 실험군의 파라핀메몰 표본은 5μm 두께로 절편한 후 silane-coated micro slides에 부착하여 hematoxylin & eosin (H&E), toluidine blue 및 trichrome 염색한 다음 광학현미경으로 100배 및 400배 시야에서 검경하였다.The prepared paraffin memol specimens of each experimental group were sectioned to a thickness of 5 μm, attached to silane-coated micro slides, stained with hematoxylin & eosin (H&E), toluidine blue, and trichrome, and then examined under an optical microscope at 100X and 400X field of view.

첨부된 도면의 도 6을 참조하면 수컷 마우스의 UV-B에 의한 피부손상으로부터 복합추출물의 보호효과를 확인하였다.Referring to FIG. 6 of the accompanying drawings, the protective effect of the complex extract from skin damage caused by UV-B in male mice was confirmed.

도 6은 실험예 5에 따른 결과를 나타낸 것이다.6 shows the results according to Experimental Example 5.

첨부된 도면의 도 6에 따른 결과, 복합추출물을 200mg/kg의 농도로 2주간 경구 투여하였을 때, 도 6과 같이 보호효과를 확인했으며, 표피 두께 감소효과도 확인되었다.As a result according to FIG. 6 of the accompanying drawings, when the complex extract was orally administered at a concentration of 200 mg/kg for 2 weeks, the protective effect as shown in FIG. 6 was confirmed, and the effect of reducing the epidermal thickness was also confirmed.

첨부된 도면의 도 6의 보호효과를 확인하기 위하여 조직학적 분석을 수행하였고, 이는 첨부된 도면의 도 7에 나타냈다.Histological analysis was performed to confirm the protective effect of FIG. 6 of the accompanying drawings, which is shown in FIG. 7 of the accompanying drawings.

도 7은 실험예 5에 따른 결과의 확인을 위하여 조직학적 분석을 수행한 것이다.7 is a histological analysis performed to confirm the results according to Experimental Example 5.

첨부된 도면의 도 7에서와 같이, 제조예 1에 따른 복합추출물의 표피부종 감소효과를 H&E Staining을 통해 확인(도 7의 1열)하였고, toluidine blue 염색을 통해 비만세포의 침윤을 억제하는 것도 확인(도 7의 2열)하였다.As shown in FIG. 7 of the accompanying drawings, the epidermal reduction effect of the complex extract according to Preparation Example 1 was confirmed through H&E staining (column 1 of FIG. 7), and inhibition of mast cell infiltration through toluidine blue staining was also confirmed. It was confirmed (column 2 in FIG. 7).

또한, trichrome staining을 통해 피부 콜라겐 보호 효과를 확인(도 7의 3열)하였다.In addition, the skin collagen protective effect was confirmed through trichrome staining (column 3 in FIG. 7 ).

실험예 6. UV-B에 의한 콜라겐 손상으로부터 피부에서의 엘라스틴과 콜라겐 단백질 발현Experimental Example 6. Expression of elastin and collagen protein in the skin from collagen damage caused by UV-B

추가로, 동물실험에서 UV-B에 의한 콜라겐 손상으로부터 피부에서의 엘라스틴과 콜라겐 단백질 발현을 알아보기 위하여, 엘라스틴 및 콜라겐 분자 각각에 특이적으로 작용하는 것으로 알려진 항체를 활용하여, Western blot으로 확인하는 실험을 수행하였다.In addition, in order to examine the expression of elastin and collagen protein in the skin from collagen damage caused by UV-B in animal experiments, using an antibody known to specifically act on elastin and collagen molecules, confirming by Western blot Experiments were performed.

이는 첨부된 도면의 도 8에 도시되어 있다.This is illustrated in FIG. 8 of the accompanying drawings.

도 8은 실험예 6에 따른 결과를 나타낸 것이다.8 shows the results according to Experimental Example 6.

첨부된 도면의 도 8에 따르면, 콜라겐 및 엘라스틴 모두, 제조예 1에 따른 복합추출물을 생쥐에게 200mg/kg 농도로 경구투여 하였을 때, 콜라겐 및 엘라스틴의 생성량이 증가하는 것을 확인하였다.According to FIG. 8 of the accompanying drawings, both collagen and elastin, when the complex extract according to Preparation Example 1 was orally administered to mice at a concentration of 200 mg/kg, it was confirmed that the amount of collagen and elastin production increased.

실험예 7. 인공피부에 따른 실험Experimental Example 7. Experiment with artificial skin

실험에 사용한 인공피부는 테고사이언스(주)에서 구입 하였으며 제조사의 매뉴얼에 따라 배양 하였으며 각각의 추출물을 세포에 전처리 하였다.The artificial skin used in the experiment was purchased from Tego Science Co., Ltd., and cultured according to the manufacturer's manual, and each extract was pretreated into the cells.

실험종료 후 파라핀블록을 제조하여 5μm 두께로 절편한 후, trichrome 염색한 다음 광학현미경으로 100배 시야에서 검경하였다. After completion of the experiment, a paraffin block was prepared and sectioned to a thickness of 5 μm, stained with trichrome, and then examined under a 100-fold field of view under an optical microscope.

실험예 7에 따른 실험결과는 첨부된 도면의 도 9에서 나타내었다.Experimental results according to Experimental Example 7 are shown in FIG. 9 of the accompanying drawings.

도 9는 실험예 7에 따른 결과를 나타낸 것이다.9 shows the results according to Experimental Example 7.

첨부된 도면의 도 9에 따른 인공세포 배양실험을 통해 제조예 1의 복합추출물의 콜라겐 합성률 평가 결과에 따르면, 상기 혼합추출물 및 비타민 C를 첨가한 실험군에서 콜라겐 합성률의 증가 효과를 확인 할 수 있다.According to the evaluation result of the collagen synthesis rate of the complex extract of Preparation Example 1 through the artificial cell culture experiment according to FIG. 9 of the accompanying drawings, the effect of increasing the collagen synthesis rate in the experimental group to which the mixed extract and vitamin C was added have.

상기에서 도면을 이용하여 서술한 것은, 본 발명의 주요 사항만을 서술한 것으로, 그 기술적 범위 내에서 다양한 설계가 가능한 만큼, 본 발명이 도면의 구성에 한정되는 것이 아님은 자명하다.What has been described above using the drawings is to describe only the main points of the present invention, and it is obvious that the present invention is not limited to the configuration of the drawings as much as various designs are possible within the technical scope.

Claims (12)

갯질경을 유효성분으로 함유하는 피부세포재생용 조성물.
A composition for skin cell regeneration containing Psyllium as an active ingredient.
청구항 1에 있어서,
상기 조성물은, 갯질경, 지채, 비쑥 및 홍삼을 이용한 추출물인 것을 특징으로 하는, 갯질경을 유효성분으로 함유하는 피부세포재생용 조성물.
The method according to claim 1,
The composition is, characterized in that the extract using the syphilis, sagebrush, mugwort and red ginseng, a composition for skin cell regeneration containing the syphilis as an active ingredient.
청구항 2에 있어서,
상기 조성물은, 갯질경 : 지채 : 비쑥 : 홍삼의 비율을 2 : 1 : 1 : 2의 비율로 하는 것을 특징으로 하는, 갯질경을 유효성분으로 함유하는 피부세포재생용 조성물.
3. The method according to claim 2,
The composition is a composition for skin cell regeneration containing a plantain plant as an active ingredient, characterized in that the ratio of spearmint: sagebrush: wormwood: red ginseng is in a ratio of 2: 1: 1: 2.
청구항 3에 있어서,
상기 조성물은,
상기 비율을 100g으로 정량하여, 50%(v/v) 에탄올 2L를 넣어 실온에서 5일 동안 추출함으로써 혼합추출물을 획득하는 것을 특징으로 하는, 갯질경을 유효성분으로 함유하는 피부세포재생용 조성물.
4. The method according to claim 3,
The composition is
The ratio is quantified as 100 g, and the mixed extract is obtained by adding 2 L of 50% (v/v) ethanol and extracting at room temperature for 5 days.
청구항 4에 있어서,
상기 조성물은,
상기 혼합추출물을 여과한 후, 감압농축기를 통해 농축하고, 동결건조기를 통해 건조하여 회수한 뒤, -20℃에 보관함으로써 획득된 복합추출물인 것을 특징으로 하는, 갯질경을 유효성분으로 함유하는 피부세포재생용 조성물.
5. The method according to claim 4,
The composition is
After filtering the mixed extract, it is concentrated through a vacuum concentrator, dried through a freeze dryer and recovered, and then stored at -20 ° C. A composition for cell regeneration.
청구항 5에 있어서,
상기 조성물은 100㎍/㎖ 이하의 농도에서는, 인간 유래 HaCat 세포의 생존율에 영향을 미치지 않는 것을 특징으로 하는, 갯질경을 유효성분으로 함유하는 피부세포재생용 조성물.
6. The method of claim 5,
The composition is 100㎍ / ㎖ or less concentration, characterized in that it does not affect the viability of human-derived HaCat cells, a composition for skin cell regeneration containing phyllophthora as an active ingredient.
청구항 5에 있어서,
상기 조성물은 인간 유래 HaCaT 세포의 배양액에 100㎍/㎖의 농도로 처리하였을 때, 과산화물에 의한 세포손상시 복합추출물의 무첨가군 대비 높은 재생률을 가지는 것을 특징으로 하는, 갯질경을 유효성분으로 함유하는 피부세포재생용 조성물.
6. The method of claim 5,
When the composition is treated at a concentration of 100 μg/ml in a culture solution of human-derived HaCaT cells, it has a higher regeneration rate compared to the group without the addition of the complex extract when cells are damaged by peroxide. A composition for skin cell regeneration.
청구항 5에 있어서,
상기 조성물은 인간 유래 HaCaT 세포의 배양액에 100㎍/㎖의 농도로 처리하였을 때, UV-B에 의한 콜라겐 손상으로부터 콜라겐 재생률이, 복합추출물의 무첨가군 대비 높은 재생률을 가지는 것을 특징으로 하는, 갯질경을 유효성분으로 함유하는 피부세포재생용 조성물.
6. The method of claim 5,
When the composition is treated at a concentration of 100 μg/ml in a culture solution of human-derived HaCaT cells, the collagen regeneration rate from UV-B-induced collagen damage is higher than that of the group without the addition of the complex extract. A composition for skin cell regeneration containing as an active ingredient.
청구항 5에 있어서,
상기 조성물은, 인간 유래 HaCaT 세포의 배양액에 100㎍/㎖의 농도로 처리하였을 때, 인간 유래 HaCaT 세포에서 UV-B에 의한 콜라겐 손상으로부터 콜라겐 재생율이 증가하는 것을 특징으로 하는, 갯질경을 유효성분으로 함유하는 피부세포재생용 조성물.
6. The method of claim 5,
The composition, when treated at a concentration of 100㎍ / ㎖ in the culture medium of human-derived HaCaT cells, characterized in that the collagen regeneration rate from UV-B-induced collagen damage in human-derived HaCaT cells is increased. A composition for skin cell regeneration containing
청구항 5에 있어서,
상기 조성물은, 인간 유래 HaCaT 세포의 배양액에 100㎍/㎖의 농도로 처리하였을 때, 인간 유래 HaCaT 세포에서 UV-B에 의한 콜라겐 손상으로부터 엘라스틴과 콜라겐 단백질의 생성량이 증가하는 것을 특징으로 하는, 갯질경을 유효성분으로 함유하는 피부세포재생용 조성물.
6. The method of claim 5,
The composition is characterized in that when the human-derived HaCaT cell culture solution is treated at a concentration of 100 μg/ml, the production of elastin and collagen protein increases from UV-B-induced collagen damage in human-derived HaCaT cells. A composition for skin cell regeneration containing plantain as an active ingredient.
청구항 5에 있어서,
상기 조성물은, UV-B에 의한 피부손상으로부터 표피부종 감소, 비만세포의 침윤 억제 및 피부 콜라겐 보호 효과를 가지는 것을 특징으로 하는, 갯질경을 유효성분으로 함유하는 피부세포재생용 조성물.
6. The method of claim 5,
The composition, characterized in that it has the effect of reducing epidermal dermatoma from skin damage caused by UV-B, inhibiting the infiltration of mast cells and protecting skin collagen, a composition for skin cell regeneration containing Psyllium as an active ingredient.
청구항 5에 있어서,
상기 조성물은 비타민 C를 참가하는 경우, 콜라겐 합성률이 증가하는 것을 특징으로 하는, 갯질경을 유효성분으로 함유하는 피부세포재생용 조성물.
6. The method of claim 5,
The composition is characterized in that when vitamin C is added, the collagen synthesis rate is increased, the composition for skin cell regeneration containing Psyllium as an active ingredient.
KR1020200058700A 2020-05-15 2020-05-15 Composition for recylce a skin cell comprising of limonium tetragonum KR102545718B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020200058700A KR102545718B1 (en) 2020-05-15 2020-05-15 Composition for recylce a skin cell comprising of limonium tetragonum

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020200058700A KR102545718B1 (en) 2020-05-15 2020-05-15 Composition for recylce a skin cell comprising of limonium tetragonum

Publications (2)

Publication Number Publication Date
KR20210141271A true KR20210141271A (en) 2021-11-23
KR102545718B1 KR102545718B1 (en) 2023-06-20

Family

ID=78695242

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020200058700A KR102545718B1 (en) 2020-05-15 2020-05-15 Composition for recylce a skin cell comprising of limonium tetragonum

Country Status (1)

Country Link
KR (1) KR102545718B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102424822B1 (en) * 2022-02-10 2022-07-28 인코스(주) Cosmetic composition for strengthening skin barrier
KR20240110304A (en) 2023-01-06 2024-07-15 경상국립대학교산학협력단 Method for cultivation of Limonium tetragonum with enhanced myricetin glycosides and its use

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101528871B1 (en) * 2012-10-31 2015-06-16 유한회사한풍제약 A pharmaceutical with anti-aging effect through cell activation, and health functional food with the pharmaceutical
KR101652956B1 (en) 2016-02-03 2016-08-31 (주)넥스젠바이오텍 Human epidermal growth factor fusion protein with increased anti-oxidant activity and cell proliferation effect and cosmetic composition for anti-wrinkle and anti-aging comprising the same as effective component

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101528871B1 (en) * 2012-10-31 2015-06-16 유한회사한풍제약 A pharmaceutical with anti-aging effect through cell activation, and health functional food with the pharmaceutical
KR101652956B1 (en) 2016-02-03 2016-08-31 (주)넥스젠바이오텍 Human epidermal growth factor fusion protein with increased anti-oxidant activity and cell proliferation effect and cosmetic composition for anti-wrinkle and anti-aging comprising the same as effective component

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Anti-wrinkle effects of halophyte extracts on UV-B-irradiated human skin fibroblast cells, 인천대학교 석사학위논문(2020.02.) 1부.* *
Biological Role of Vitamin C in Keratinocytes, Nutrition Reviews, 63(3), 81-90(2005.03.) 1부.* *
Molecules, 25(6), 1331(2020.03.14.) 1부.* *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102424822B1 (en) * 2022-02-10 2022-07-28 인코스(주) Cosmetic composition for strengthening skin barrier
KR20240110304A (en) 2023-01-06 2024-07-15 경상국립대학교산학협력단 Method for cultivation of Limonium tetragonum with enhanced myricetin glycosides and its use

Also Published As

Publication number Publication date
KR102545718B1 (en) 2023-06-20

Similar Documents

Publication Publication Date Title
JP6929954B2 (en) Method for improving gingival inflammation and periodontitis by antibacterial, antioxidant, anti-inflammatory, suppression and regeneration of alveolar bone loss of Moringa leaf extract and Tochu extract complex
JP6054700B2 (en) Desugaring agent and external preparation for skin
KR100950437B1 (en) Herbal composition for the prevention of depilation and improvement of hair growth and method for preparing the same
KR102545718B1 (en) Composition for recylce a skin cell comprising of limonium tetragonum
KR20180130080A (en) Anti-inflammatory composition comprising extracts of grasses and preparing method thereof
KR101794006B1 (en) Anti inflammatory comprising plant extract
KR20180087592A (en) Cometic composition for skin whitening, anti-wrinkle and skin regeneration comprising nine times-steaming ginseng extract and water-soluble pearl as active ingredient
KR102323101B1 (en) Composition for improving hair and scalp condition coprising extract of hydrangea serrata
KR102012872B1 (en) High concentrate for beverage containing black raspberry, plantaginis asiatica l., schizandra chinensis, lycii fructus and torilis japonica decandolle and the high concentrate for beverage prepared from the same
KR20110075742A (en) Cosmetic composition containing polygonum multiflorum extracts, jujube extracts and hibiscus manihot extracts for moisturizing skin
KR102209663B1 (en) Composition for preventing or treating skin disease comprising extract of Spiraea prunifolia simpliciflora
JP2017531645A (en) A composition for preventing hair loss or promoting hair growth, comprising an extract of scutellaria alpina
KR20220163542A (en) Composition for anti-oxidation, anti-inflammation, and anti-pollution containing an extraction of Backhousia citriodora and Sparassis crispa
JP6629271B2 (en) Endo180 production promoter
KR20170091939A (en) Composition for promoting hair growth or preventing hair loss comprising extract of ginseng floral axis
KR101684869B1 (en) Bath agent containing ceriporia lacerata extract
KR102316334B1 (en) Food or Cosmetic Composition For Improving Hair Health Containing Complex Natural Product Extract
KR102485384B1 (en) Cosmetic composition with multi lamellar liposome encapsulated with the extract of Adenophora triphylla var. japonica HARA. and the extract of Siegesbeckiae Herba for improvement of acne
KR102431553B1 (en) Cosmetic composition for preventing hair loss and promoting hair growth
KR102209664B1 (en) Composition for preventing or treating skin disease comprising extract of Euonymus alatus ciliatodentatus
US11684563B2 (en) Plant derived active ingredient comprising plant extracts
KR102162843B1 (en) Composition for preventing or treating skin disease comprising extract of Corylus heterophylla
KR20180078433A (en) Anti-obesity composition comprising yomena aster extract
KR101682458B1 (en) Cosmetic composition for slimming
KR101434300B1 (en) Cosmetic Composition Comprising Vitis flexuosa Thunb, Penthorum chinense PURSH Extract for Skin Whitening

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
AMND Amendment
X701 Decision to grant (after re-examination)
GRNT Written decision to grant